The NetworkNewsAudio News Podcast

NetworkNewsWire Editorial Coverage: Although some people may be surprised, today’s world is full of robots. While these electro-mechanical devices may not be in the form of a cyborg RoboCop, they’re already serving people in countless ways. Industrial robots are a primary application today, with the world becoming accustomed to, and even expecting, life-altering technologies as robots shuttle people around, perform surgeries, keep communities safe, and much more. A global market summary by the International Federation of Robotics showed the robot trend accelerating, with a record 517,000 new industrial robots installed in factories around the world in 2021, up 31% from 2020. A host of innovative companies — including Knightscope, Inc. (NASDAQ: KSCP) (Profile), Velodyne Lidar Inc. (NASDAQ: VLDR), Pacific Gas & Electric Co. (NYSE: PCG), NVIDIA Corporation (NASDAQ: NVDA) and Palantir Technologies Inc. (NYSE: PLTR) — are investing in, developing and deploying leading-edge technology that is proving the value of robots in everyday lives or increasing their long-term potential.  

• Approximately 2.7 million industrial robots were in use in 2020, creating a global market valued at $55 billion that is expected to reach $165 billion by 2028. 

• Knightscope robots have 1.8-plus million hours of operation, have been documented to deter criminal activity and have proven invaluable in convictions of crimes. 
• Knightscope completed its first acquisition in October, buying CASE Emergency Systems. 
• November has seen a surge of new orders, activations for Knightscope crime-fighting robots and CASE emergency phones. 

Click here to view the custom infographic of the Knightscope, Inc. editorial. 

NetworkNewsWire Editorial Coverage: Although some people may be surprised, today’s world is full of robots. While these electro-mechanical devices may not be in the form of a cyborg RoboCop, they’re already serving people in countless ways. Industrial robots are a primary application today, with the world becoming accustomed to, and even expecting, life-altering technologies as robots shuttle people around, perform surgeries, keep communities safe, and much more. A global market summary by the International Federation of Robotics showed the robot trend accelerating, with a record 517,000 new industrial robots installed in factories around the world in 2021, up 31% from 2020. A host of innovative companies — including Knightscope, Inc. (NASDAQ: KSCP) (Profile), Velodyne Lidar Inc. (NASDAQ: VLDR), Pacific Gas & Electric Co. (NYSE: PCG), NVIDIA Corporation (NASDAQ: NVDA) and Palantir Technologies Inc. (NYSE: PLTR) — are investing in, developing and deploying leading-edge technology that is proving the value of robots in everyday lives or increasing their long-term potential.  

• Approximately 2.7 million industrial robots were in use in 2020, creating a global market valued at $55 billion that is expected to reach $165 billion by 2028. 

• Knightscope robots have 1.8-plus million hours of operation, have been documented to deter criminal activity and have proven invaluable in convictions of crimes. 
• Knightscope completed its first acquisition in October, buying CASE Emergency Systems. 
• November has seen a surge of new orders, activations for Knightscope crime-fighting robots and CASE emergency phones. 

Click here to view the custom infographic of the Knightscope, Inc. editorial. 

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers CNS Pharmaceuticals’ recent announcement highlighting the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer.

To hear the audio production, visit: https://www.nnw.fm/TCHxT

To read the original press release, visit: https://nnw.fm/js5dD

“Our primary focus continues to be on advancing the clinical development of Berubicin as a potential treatment option for this devastating disease. Over the course of this year, we have worked diligently to expand patient eligibility for our potentially pivotal trial and bolster our international presence now realized with the activation of the first two European clinical trial sites,” John Climaco, CEO of CNS Pharmaceuticals, stated in the news release. “This is a true testament to our team's commitment to and the execution of this important clinical program.”

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers CNS Pharmaceuticals’ recent announcement highlighting the activation of its first clinical trial sites in Europe for the ongoing potentially pivotal global trial evaluating Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), one of the most aggressive types of brain cancer.

To hear the audio production, visit: https://www.nnw.fm/TCHxT

To read the original press release, visit: https://nnw.fm/js5dD

“Our primary focus continues to be on advancing the clinical development of Berubicin as a potential treatment option for this devastating disease. Over the course of this year, we have worked diligently to expand patient eligibility for our potentially pivotal trial and bolster our international presence now realized with the activation of the first two European clinical trial sites,” John Climaco, CEO of CNS Pharmaceuticals, stated in the news release. “This is a true testament to our team's commitment to and the execution of this important clinical program.”

BlockQuarry Corp. (OTC: BLQC), a Texas-based company with commercial-stage operations in cryptocurrency mine hosting and self-mining in the Southeast United States, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers BlockQuarry’s recent update on its provisional and unaudited Q3 performance projections, as well as highlights from its financial performance for the three months ended June 30, 2022.  

To hear the audio production, visit: https://www.nnw.fm/nFqTT   

To read the original press release, visit: https://www.nnw.fm/o2xvh   

“We had a fantastic 2021, but we believe 2022 is on pace to significantly raise the bar,” Alonzo Pierce, President and Chair of BlockQuarry, stated in the news release. “Our hosting revenue this year has already surpassed what we produced from that segment for the whole year in 2021. Moreover, due to our market positioning and signed agreements with major partners, 2022 appears set to be our best year ever on both the top and bottom line, with Q3 on pace to show strong growth on both a sequential and year-over-year basis, and we are excited to further bolster our positioning and performance trajectory into year end.” 

BlockQuarry Corp. (OTC: BLQC), a Texas-based company with commercial-stage operations in cryptocurrency mine hosting and self-mining in the Southeast United States, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers BlockQuarry’s recent update on its provisional and unaudited Q3 performance projections, as well as highlights from its financial performance for the three months ended June 30, 2022.  

To hear the audio production, visit: https://www.nnw.fm/nFqTT   

To read the original press release, visit: https://www.nnw.fm/o2xvh   

“We had a fantastic 2021, but we believe 2022 is on pace to significantly raise the bar,” Alonzo Pierce, President and Chair of BlockQuarry, stated in the news release. “Our hosting revenue this year has already surpassed what we produced from that segment for the whole year in 2021. Moreover, due to our market positioning and signed agreements with major partners, 2022 appears set to be our best year ever on both the top and bottom line, with Q3 on pace to show strong growth on both a sequential and year-over-year basis, and we are excited to further bolster our positioning and performance trajectory into year end.” 

Quantum computing has moved from research to reality, as companies increasingly turn to the power of quantum mechanical effects to solve complex computational problems and maximize efficiencies throughout their businesses. When considering the quantum computing landscape, it’s important to note that not all quantum computing technologies are the same and approaches vary. While some companies are focused on building quantum systems that won’t be available for many years to come, others are offering real, practical quantum computing applications available today to help tackle a myriad of complex business challenges. Hundreds of early quantum applications have already been built to address complexities in resource scheduling, mobility, logistics, drug discovery, portfolio optimization, and manufacturing processes. Despite a growing marketplace of quantum computing players, only a handful are currently commercially viable. Industry pioneer D-Wave Quantum Inc. (NYSE: QBTS) (Profile) is the first company with real-world commercial annealing quantum computing services and the only company building both annealing and gate-based quantum computing products. D-Wave, which just became public via a SPAC merger, is at the vanguard of the quantum sea change in computing alongside other computer juggernauts such as Microsoft Corporation (NASDAQ: MSFT), Alphabet Inc. (NASDAQ: GOOGL), International Business Machines Corporation (NYSE: IBM) and Honeywell International Inc. (NASDAQ: HON).

Quantum computing has moved from research to reality, as companies increasingly turn to the power of quantum mechanical effects to solve complex computational problems and maximize efficiencies throughout their businesses. When considering the quantum computing landscape, it’s important to note that not all quantum computing technologies are the same and approaches vary. While some companies are focused on building quantum systems that won’t be available for many years to come, others are offering real, practical quantum computing applications available today to help tackle a myriad of complex business challenges. Hundreds of early quantum applications have already been built to address complexities in resource scheduling, mobility, logistics, drug discovery, portfolio optimization, and manufacturing processes. Despite a growing marketplace of quantum computing players, only a handful are currently commercially viable. Industry pioneer D-Wave Quantum Inc. (NYSE: QBTS) (Profile) is the first company with real-world commercial annealing quantum computing services and the only company building both annealing and gate-based quantum computing products. D-Wave, which just became public via a SPAC merger, is at the vanguard of the quantum sea change in computing alongside other computer juggernauts such as Microsoft Corporation (NASDAQ: MSFT), Alphabet Inc. (NASDAQ: GOOGL), International Business Machines Corporation (NYSE: IBM) and Honeywell International Inc. (NASDAQ: HON).

Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114 million adults in this country are at risk from damage caused by the long-term force of blood beating against artery walls, which often leads to disease and death. The good news is that hypertension is treatable and manageable through lifestyle changes and medications. Fact is, there are several approved blood pressure medications on the market, yet only about one in five people diagnosed with hypertension take medication. Why so few? Unfortunately, the side effects of these medications often outweigh the benefits. However, a new hypertension blockbuster may be imminent. A safer, better-tolerated drug candidate just marked a major milestone on the path to approval and commercialization. A global innovator in drug-delivery platforms, Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile) has been quietly progressing through clinical processes and amassing a growing body of evidence that strongly supports use of its patented DehydraTECH(TM) technology in hypertension therapeutics. The company’s valuation looks attractive with arguably significant upside as it looks to rub shoulders and gain attention from the likes of Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Novartis AG (NYSE: NVS) — all aiming to capitalize on what may be the next blockbuster and defend hundreds of millions from a silent killer.

Nearly half of all American adults suffer from hypertension (high blood pressure), often referred to as a silent killer. More than 114 million adults in this country are at risk from damage caused by the long-term force of blood beating against artery walls, which often leads to disease and death. The good news is that hypertension is treatable and manageable through lifestyle changes and medications. Fact is, there are several approved blood pressure medications on the market, yet only about one in five people diagnosed with hypertension take medication. Why so few? Unfortunately, the side effects of these medications often outweigh the benefits. However, a new hypertension blockbuster may be imminent. A safer, better-tolerated drug candidate just marked a major milestone on the path to approval and commercialization. A global innovator in drug-delivery platforms, Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile) has been quietly progressing through clinical processes and amassing a growing body of evidence that strongly supports use of its patented DehydraTECH(TM) technology in hypertension therapeutics. The company’s valuation looks attractive with arguably significant upside as it looks to rub shoulders and gain attention from the likes of Pfizer Inc. (NYSE: PFE), Merck & Company Inc. (NYSE: MRK), AstraZeneca PLC (NASDAQ: AZN) and Novartis AG (NYSE: NVS) — all aiming to capitalize on what may be the next blockbuster and defend hundreds of millions from a silent killer.

Greenland Technologies Holding Corporation (NASDAQ: GTEC), a technology developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling machineries and vehicles, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers the Company’s recent announcement of availability of its latest electric industrial vehicle, the GEL-5000, under its new clean industrial heavy equipment brand, HEVI.

To hear the audio production, visit: https://www.nnw.fm/DZAG7 

To read the original press release, visit: https://nnw.fm/qSskN

The new GEL-5000 is a 5.0-ton rated load all-electric lithium wheeled front loader that boasts strong power, approximately 40,000 pounds operating weight and increased payload options, making it a clean, green industrial vehicle with a rapid two-hour charge time and nine hours of operation time per charge. 

Greenland Technologies Holding Corporation (NASDAQ: GTEC), a technology developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling machineries and vehicles, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers the Company’s recent announcement of availability of its latest electric industrial vehicle, the GEL-5000, under its new clean industrial heavy equipment brand, HEVI.

To hear the audio production, visit: https://www.nnw.fm/DZAG7 

To read the original press release, visit: https://nnw.fm/qSskN

The new GEL-5000 is a 5.0-ton rated load all-electric lithium wheeled front loader that boasts strong power, approximately 40,000 pounds operating weight and increased payload options, making it a clean, green industrial vehicle with a rapid two-hour charge time and nine hours of operation time per charge. 

The world may be on the cusp of a new generation of computing. Its name? Quantum computing. Much like its precursors, quantum computing doesn’t have a sole inventor or a single brand; it is the collective product of decades of work by many of the brightest minds in science and technology. The nascent industry is highly complex employing varied approaches to harness the power of quantum mechanics to solve challenges that classic computers simply cannot handle. A paradigm shift of computing may be coming, and it would have a far-reaching impact. Currently real, practical quantum computing applications are helping solve a myriad of business challenges. Hundreds of early quantum applications have been built attempting to address resource scheduling, mobility, logistics, drug-discovery, portfolio optimization and manufacturing processes. The world’s first commercial supplier of quantum computers, D-Wave Systems Inc. (“D-Wave”) is a leader in the development and delivery of quantum computing systems, software, and services and is the only company building both annealing quantum computers and gate-model quantum computers. D-Wave’s customers include more than two dozen of the Forbes Global 2000 companies, including Volkswagen, Accenture, NEC Corporation and Lockheed Martin. Of major interest is that D-Wave is working to complete a business combination transaction (Business Combination) with blank-check company DPCM Capital Inc. (NYSE: XPOA) (DPCM Capital Profile) to bring it public. In geekdom, D-Wave is already a household name, but as a public company, it is expected to gain even greater recognition for its products and services by helping to bring quantum computing into the mainstream. Other companies, such as Microsoft Corporation (NASDAQ: MSFT), Alphabet Inc. (NASDAQ: GOOGL), International Business Machines Corporation (NYSE: IBM) and Honeywell International Inc. (NASDAQ: HON), are also seeking to make significant contributions to quantum computing.

The world may be on the cusp of a new generation of computing. Its name? Quantum computing. Much like its precursors, quantum computing doesn’t have a sole inventor or a single brand; it is the collective product of decades of work by many of the brightest minds in science and technology. The nascent industry is highly complex employing varied approaches to harness the power of quantum mechanics to solve challenges that classic computers simply cannot handle. A paradigm shift of computing may be coming, and it would have a far-reaching impact. Currently real, practical quantum computing applications are helping solve a myriad of business challenges. Hundreds of early quantum applications have been built attempting to address resource scheduling, mobility, logistics, drug-discovery, portfolio optimization and manufacturing processes. The world’s first commercial supplier of quantum computers, D-Wave Systems Inc. (“D-Wave”) is a leader in the development and delivery of quantum computing systems, software, and services and is the only company building both annealing quantum computers and gate-model quantum computers. D-Wave’s customers include more than two dozen of the Forbes Global 2000 companies, including Volkswagen, Accenture, NEC Corporation and Lockheed Martin. Of major interest is that D-Wave is working to complete a business combination transaction (Business Combination) with blank-check company DPCM Capital Inc. (NYSE: XPOA) (DPCM Capital Profile) to bring it public. In geekdom, D-Wave is already a household name, but as a public company, it is expected to gain even greater recognition for its products and services by helping to bring quantum computing into the mainstream. Other companies, such as Microsoft Corporation (NASDAQ: MSFT), Alphabet Inc. (NASDAQ: GOOGL), International Business Machines Corporation (NYSE: IBM) and Honeywell International Inc. (NASDAQ: HON), are also seeking to make significant contributions to quantum computing.

• Listing follows the successful launch of the Company’s commercial-scale AI turnkey SaaS in-real-time knowledge engine called ‘Pluaris.’
• Pluaris solves the information overload problem commonly experienced at work and at home. The Company believes the personal knowledge management (KM) market opportunity has over 1 billion users and is currently underserved.
• NOWG begins trading today.

Nowigence, Inc. (OTCQB: NOWG) announces today that its common stock will begin trading on the OTCQB Venture Market, the mid-tier OTC equity market, which lists primarily early-stage and developing companies in the U.S. and international markets.

To view the full press release, visit https://nnw.fm/GD8g6

• Listing follows the successful launch of the Company’s commercial-scale AI turnkey SaaS in-real-time knowledge engine called ‘Pluaris.’
• Pluaris solves the information overload problem commonly experienced at work and at home. The Company believes the personal knowledge management (KM) market opportunity has over 1 billion users and is currently underserved.
• NOWG begins trading today.

Nowigence, Inc. (OTCQB: NOWG) announces today that its common stock will begin trading on the OTCQB Venture Market, the mid-tier OTC equity market, which lists primarily early-stage and developing companies in the U.S. and international markets.

To view the full press release, visit https://nnw.fm/GD8g6

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers EverGen’s recent announcement of its entry into definitive agreements with Northeast Renewables LP (“Northeast”) to acquire a 50% interest in a portfolio of RNG development projects.

To read the original press release, visit: https://nnw.fm/PRohG

As detailed in the news release, Project Radius, located in southern Ontario, is a late-development-stage portfolio of three high-quality, on-farm RNG projects, collectively capable of producing roughly 1.7 million GJ/year of RNG that will contribute to the reduction of emissions from agricultural operations in southern Ontario. Each of the three projects is expected to produce approximately 550,000 GJ/year and will be constructed throughout 2023 and 2024.

“The acquisition of Project Radius provides a foothold in Ontario - a new and strategic jurisdiction in which EverGen can continue to participate in the consolidation and growth of the RNG industry in the near-term, as well as benefit from project economics in line with or exceeding those we have seen with our initial projects,” Chase Edgelow, CEO of EverGen, stated in the news release. “Working alongside Northeast to advance the projects, EverGen will deliver on our platform expansion commitments with the potential to exceed 1,000,000 GJ of RNG production annually. Ontario has an abundant amount of excess organic feedstock, and as a leader in the RNG industry, EverGen can develop the sustainable infrastructure that contributes to carbon-negative energy production and the greening of the province.”

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, today announces that it has been featured in a broadcast via NetworkNewsAudio (“NNA”), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers EverGen’s recent announcement of its entry into definitive agreements with Northeast Renewables LP (“Northeast”) to acquire a 50% interest in a portfolio of RNG development projects.

To read the original press release, visit: https://nnw.fm/PRohG

As detailed in the news release, Project Radius, located in southern Ontario, is a late-development-stage portfolio of three high-quality, on-farm RNG projects, collectively capable of producing roughly 1.7 million GJ/year of RNG that will contribute to the reduction of emissions from agricultural operations in southern Ontario. Each of the three projects is expected to produce approximately 550,000 GJ/year and will be constructed throughout 2023 and 2024.

“The acquisition of Project Radius provides a foothold in Ontario - a new and strategic jurisdiction in which EverGen can continue to participate in the consolidation and growth of the RNG industry in the near-term, as well as benefit from project economics in line with or exceeding those we have seen with our initial projects,” Chase Edgelow, CEO of EverGen, stated in the news release. “Working alongside Northeast to advance the projects, EverGen will deliver on our platform expansion commitments with the potential to exceed 1,000,000 GJ of RNG production annually. Ontario has an abundant amount of excess organic feedstock, and as a leader in the RNG industry, EverGen can develop the sustainable infrastructure that contributes to carbon-negative energy production and the greening of the province.”

Seems like yesterday people were smoking cigarettes everywhere; many people still have memories of Grandpa puffing on his Camels. It wasn’t until 1993 that smoking was banned in hospitals and on airplanes in 1998. Despite these and many other restrictions, the global market for nicotine-based products remains incredibly robust. Total global retail sales associated with the nicotine ecosystem during 2020 reached approximately $853 billion with around 5.2 trillion retail cigarette sticks sold. Nicotine isn’t just big business, it’s huge business, and companies are constantly looking for ways to keep and grow market share.

The majors are evermore turning to innovation and alternative delivery methods to achieve their objectives. An example of that is the breakthrough technology of Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile) and its patented DehydraTECH(TM) delivery platform. Suitable for use across a wide range of product formats such as pharmaceuticals, nutraceuticals and over-the-counter products, Lexaria’s DehydraTECH also increases the delivery characteristics of orally administered nicotine.

Seems like yesterday people were smoking cigarettes everywhere; many people still have memories of Grandpa puffing on his Camels. It wasn’t until 1993 that smoking was banned in hospitals and on airplanes in 1998. Despite these and many other restrictions, the global market for nicotine-based products remains incredibly robust. Total global retail sales associated with the nicotine ecosystem during 2020 reached approximately $853 billion with around 5.2 trillion retail cigarette sticks sold. Nicotine isn’t just big business, it’s huge business, and companies are constantly looking for ways to keep and grow market share.

The majors are evermore turning to innovation and alternative delivery methods to achieve their objectives. An example of that is the breakthrough technology of Lexaria Bioscience Corp. (NASDAQ: LEXX) (Profile) and its patented DehydraTECH(TM) delivery platform. Suitable for use across a wide range of product formats such as pharmaceuticals, nutraceuticals and over-the-counter products, Lexaria’s DehydraTECH also increases the delivery characteristics of orally administered nicotine.